You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
昆藥集團(600422.SH):昆中藥擬在雲南滇中新區設立醫藥流通企業
格隆匯 11-20 18:06

格隆匯11月20日丨昆藥集團(600422.SH)公佈,目前,昆明中藥廠有限公司(“昆中藥”)產品直接由各地的經銷商自行配送銷售,為了適應兩票制、營改增等政策實施,完善昆中藥營銷渠道建設,昆中藥擬在雲南滇中新區設立醫藥流通企業。

投資標的名稱:雲南厚安堂醫藥有限公司(暫定名,最後以工商登記部門核准為依據,“厚安堂醫藥”);厚安堂醫藥註冊資本為人民幣1000萬元整,以現金認繳出資,實際出資進度根據公司經營需求分期出資。厚安堂醫藥經營範圍(暫定,以工商登記部門核准為依據):中藥材、中藥飲片、中成藥、化學藥製劑、化學原料藥、抗生素原料藥、生化藥品、醫療器械、保健食品、預包裝食品、清毒劑、消毒器械、衞生用品、化粧品、乳製品、農副產品、勞動防護用品、消毒產品、計劃生育用品、日用百貨、辦公用品的銷售;倉儲服務;醫用設備的租賃及銷售;物流配送服務;普通貨物運輸;自有房屋租賃;代儲代配服務(依法須經批准的項目,經相關部門批准後方可開展經營活動)。

厚安堂醫藥的成立預計對公司2019年度的資產總額、淨資產和淨利潤等不構成重大影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account